Infection, Fungal: Clinical Trials

8 trials for Infection, Fungal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed, 2 recruiting, 1 not yet recruiting. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1
Phase 32Completed 1, Unknown 1

Follow Infection, Fungal: new trials by email Literature Review of Infection, Fungal trials Research Report on Infection, Fungal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.
Observational - Invasive Fungal Infections, Invasive Bacterial Infection
Not yet recruitingKirby Institute3002024-03-012024-02-20
How to Reduce Unnecessary Blood Cultures: Construction and Validation of a Predictive Score for Blood Culture Positivity in Intensive Care
no intervention - Infection, Bacterial, Infection, Fungal
CompletedUniversity Hospital, Tours24112022-11-222024-03-01
PK/PD of Caspofungin in Children Severe Infection
Caspofungin - Pharmacokinetics, Infection, Fungal
RecruitingChildren's Hospital of Fudan University602022-10-012026-02-17
Point-of-care Tests for Bacterial Vaginosis and Candidosis
SavvyCheck Vaginal Yeast Test, OSOM BVBLUE Test - Infection, Bacterial, Infection, Fungal
UnknownMedical University of Vienna4002020-02-142021-03-19
Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.
BDG analysis - Infection, Fungal
UnknownAssistance Publique - Hôpitaux de Paris20002018-12-122021-01-26
Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.
Cumin seed extract, clotrimazole - Infection, Fungal
Phase 2 / Phase 3CompletedAssiut University1002018-03-012020-06-09
Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis
Group 1 Natamycin 5% Suspension + voriconazole 1% eye drops; Group 2 Natamycin 5% Suspension + Vehicle eye drops - Infection, Fungal
Phase 2 / Phase 3UnknownL.V. Prasad Eye Institute552017-01-012017-07-26
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
Gene Z or other rapid diagnostic techniques developed in our lab (as of 2018 not using Gene Z - now using In-Dx along with other developed techniquesregularly) - Sepsis, Systemic Inflammatory Response Syndrome
RecruitingMichigan State University25002015-06-012026-06-08

Narrower conditions

Mycoses (8)  ·  Bacterial Infections (4)  ·  Bacteremia (1)  ·  Candidemia (1)  ·  Candidiasis (1)  ·  Coinfection (1)  ·  Coronavirus Infections (1)  ·  Invasive Fungal Infections (1)  ·  Premature Birth (1)  ·  Sepsis (1)  ·  Soft Tissue Infections (1)  ·  Systemic Inflammatory Response Syndrome (1)  ·  Vaginosis, Bacterial (1)

Broader conditions

Bacterial Infections and Mycoses (8)  ·  Infections (8)  ·  Inflammation (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Sepsis (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Candidiasis (1)  ·  Candidiasis, Invasive (1)  ·  Coronaviridae Infections (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Fungemia (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)

Interventions

Caspofungin (1)  ·  Clotrimazole (1)  ·  Ophthalmic Solutions (1)  ·  Suspensions (1)  ·  Voriconazole (1)  ·  Watchful Waiting (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Children's Hospital of Fudan University (1)  ·  Kirby Institute (1)  ·  L.V. Prasad Eye Institute (1)  ·  Medical University of Vienna (1)  ·  Michigan State University (1)  ·  University Hospital, Tours (1)

Countries

France (2)  ·  Austria (1)  ·  China (1)  ·  Egypt (1)  ·  India (1)  ·  United States (1)

Top investigators

Guoping Lu, doctor (1)  ·  Herbert Kiss, MD MBA (1)  ·  Mary J Hughes, DO (1)

Results publications

PMID 15232472, PMID 16127033, PMID 22018278, PMID 23315320, PMID 25097069, PMID 41365527, PMID 41468548